Cargando…
Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β
Type I IFNs, such as interferon alpha and interferon beta, are key regulators of the adaptive immune response during infectious diseases. Type I IFNs are induced upon infection, bind interferon α/β receptors on T-cells and activate intracellular pathways. The activating and inhibitory consequences o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071872/ https://www.ncbi.nlm.nih.gov/pubmed/33912177 http://dx.doi.org/10.3389/fimmu.2021.652965 |
_version_ | 1783683799932993536 |
---|---|
author | Jans, Jop Unger, Wendy W. Raeven, Elisabeth A. M. Simonetti, Elles R. Eleveld, Marc J. de Groot, Ronald de Jonge, Marien I. Ferwerda, Gerben |
author_facet | Jans, Jop Unger, Wendy W. Raeven, Elisabeth A. M. Simonetti, Elles R. Eleveld, Marc J. de Groot, Ronald de Jonge, Marien I. Ferwerda, Gerben |
author_sort | Jans, Jop |
collection | PubMed |
description | Type I IFNs, such as interferon alpha and interferon beta, are key regulators of the adaptive immune response during infectious diseases. Type I IFNs are induced upon infection, bind interferon α/β receptors on T-cells and activate intracellular pathways. The activating and inhibitory consequences of type I IFN-signaling are determined by cell type and cellular environment. The neonatal immune system is associated with increased vulnerability to infectious diseases which could partly be explained by an immature CD4(+) T-cell compartment. Here, we show low IFN-β-mediated inhibition of CD4(+) T-cell proliferation, phosphorylation of retinoblastoma protein and cytokine production in human newborns compared to adults. In addition, both naïve and total newborn CD4(+) T-cells are unable to induce the cell-cycle inhibitor p21 upon exposure to IFN-β in contrast to adults. The distinct IFN-β-signaling in newborns provides novel insights into T cell functionality and regulation of T cell-dependent inflammation during early life immune responses. |
format | Online Article Text |
id | pubmed-8071872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80718722021-04-27 Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β Jans, Jop Unger, Wendy W. Raeven, Elisabeth A. M. Simonetti, Elles R. Eleveld, Marc J. de Groot, Ronald de Jonge, Marien I. Ferwerda, Gerben Front Immunol Immunology Type I IFNs, such as interferon alpha and interferon beta, are key regulators of the adaptive immune response during infectious diseases. Type I IFNs are induced upon infection, bind interferon α/β receptors on T-cells and activate intracellular pathways. The activating and inhibitory consequences of type I IFN-signaling are determined by cell type and cellular environment. The neonatal immune system is associated with increased vulnerability to infectious diseases which could partly be explained by an immature CD4(+) T-cell compartment. Here, we show low IFN-β-mediated inhibition of CD4(+) T-cell proliferation, phosphorylation of retinoblastoma protein and cytokine production in human newborns compared to adults. In addition, both naïve and total newborn CD4(+) T-cells are unable to induce the cell-cycle inhibitor p21 upon exposure to IFN-β in contrast to adults. The distinct IFN-β-signaling in newborns provides novel insights into T cell functionality and regulation of T cell-dependent inflammation during early life immune responses. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8071872/ /pubmed/33912177 http://dx.doi.org/10.3389/fimmu.2021.652965 Text en Copyright © 2021 Jans, Unger, Raeven, Simonetti, Eleveld, de Groot, de Jonge and Ferwerda https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Jans, Jop Unger, Wendy W. Raeven, Elisabeth A. M. Simonetti, Elles R. Eleveld, Marc J. de Groot, Ronald de Jonge, Marien I. Ferwerda, Gerben Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β |
title | Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β |
title_full | Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β |
title_fullStr | Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β |
title_full_unstemmed | Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β |
title_short | Lack of Cell Cycle Inhibitor p21 and Low CD4(+) T Cell Suppression in Newborns After Exposure to IFN-β |
title_sort | lack of cell cycle inhibitor p21 and low cd4(+) t cell suppression in newborns after exposure to ifn-β |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071872/ https://www.ncbi.nlm.nih.gov/pubmed/33912177 http://dx.doi.org/10.3389/fimmu.2021.652965 |
work_keys_str_mv | AT jansjop lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT ungerwendyw lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT raevenelisabetham lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT simonettiellesr lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT eleveldmarcj lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT degrootronald lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT dejongemarieni lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb AT ferwerdagerben lackofcellcycleinhibitorp21andlowcd4tcellsuppressioninnewbornsafterexposuretoifnb |